This is a study of the morphology and transbilayer lipid distribution of human erythrocytes treated with chlorpromazine Ž . w 14 x CPZ over extended time courses. At 08C, treatment of dilauroylphosphatidyl 1-C choline-labeled erythrocytes with 120 Ž . m M CPZ produced an immediate stomatocytic transformation t -5 min with no concurrent change in transbilayer 1r2 distribution of radiolabeled lipid, as determined by bovine serum albumin extractability. At 378C, CPZ treatment of cells Ž . produced two sequential morphological effects: immediate stomatocytosis t -1 min with no concurrent change in 1r2 radiolabel transbilayer distribution, followed by gradual increase in stomatocytic extent over several hours, with concurrent redistribution of radiolabeled lipid to the inner monolayer. Cells pretreated with vanadate at 378C exhibited a triphasic morphological response: CPZ produced immediate stomatocytosis, followed by a transient reversion to echinocytes lasting about 2 h, before returning to stomatocytic morphologies over the next several hours. The echinocytic reversion was accompanied by exposure of phosphatidylserine on the cell surface, as indicated by increased activation of exogenous prothrombinase. These findings suggest that while CPZ induces transbilayer lipid redistribution over extended time periods Ž . which may mediate the complex morphological transformations observed , the early stomatocytic response elicited by addition of CPZ is not due to lipid reorganization.
Introduction

Ž
. 1 Chlorpromazine CPZ is a phenothiazine drug used in treatment of schizophrenia. Its mode of action at the cellular level remains elusive; hence, much effort has aimed to characterize its interaction with ) Ž . Corresponding author. Fax: q1 415 7234817. 1 Abbreviations: BSA: bovine serum albumin; CPZ: chlorpromazine; DLPC: dilauroylphosphatidylcholine; DLPS: dilauroylphosphatidylserine; dpm: disintegrations per minute; hct: hematocrit; MI: morphological index; PC: phosphatidylcholine; PS: phosphatidylserine; rbc: red blood cell. various membrane systems. For example, CPZ-membrane interactions have been implicated in drug-inw x duced effects on mitochondrial respiration 1 and w x sperm motility 2-4 .
Ž . The human erythrocyte rbc , having only one membrane and no internal organelles, is an ideal cell system for studying basic drug-biomembrane interactions. The lipids composing the erythrocyte membrane are distributed asymmetrically across the bi-Ž w x . layer see Refs. 5,6 for reviews . Choline-containing Ž . phospholipids, phosphatidylcholine PC and Ž . sphingomyelin SM , are located mainly in the outer monolayer of the membrane, while aminophospho-Ž . lipids, phosphatidylserine PS and phos-Ž . phatidylethanolamine PE , are localized in the inner w x monolayer 7,8 . Lipid asymmetry control has been implicated in such physiological functions as removal w x of senescent erythrocytes from circulation 9-11 and w x hemostasis 12,13 . Lipid asymmetry is actively maintained by a vanadate-sensitive aminophospho-Ž . lipid translocase flippase that transports PS and PE w x from the outer to inner monolayer [14] [15] [16] . Recent studies have produced evidence that CPZ disrupts this asymmetry, inducing a transbilayer redistribution Ž . w x scrambling of membrane lipid 17,18 . However, the most pronounced membrane effect seen in CPZ-treated erythrocytes is a transformation from discoid to cupped morphology. To explain this w x change in shape, Sheetz and Singer 19 proposed a bilayer couple hypothesis, whereby amphipathic agents intercalating preferentially into the outer monolayer of the membrane bilayer would produce a net expansion of the outer monolayer, producing an Ž . outward buckling echinocytosis or crenation , while amphipaths intercalating preferentially into the inner Ž . monolayer such as CPZ would produce an inward Ž . cupping or buckling stomatocytosis . Demonstration that the net negatively-charged phospholipids are low x calized in the membrane inner monolayer 7,8 provided a physical rationale for the inner monolayer disposition of cationic amphipaths like CPZ, and direct evidence for this amphipath sequestration has w x been reported 20 . While inner monolayer intercalation provides a straightforward explanation for the observed shape change, membrane effects such as CPZ-induced lipid scrambling could play a role in the w x shape change mechanism 18 . In this study, the relationship between these two CPZ-induced effects was investigated further.
Materials and methods
Materials
Chlorpromazine hydrochloride, sodium orthovana- . Dilauroylphosphatidyl 1-C choline C-DLPC was synthesized based on previously published methw x ods 21,22 . Lipid was purified on tapered silica gel G preparative thin-layer chromatography plates Ž . A n a lte c h , I n c ., N e w a r k , D E in Ž . chloroformrmethanolrformic acid 65:30:4, vrv . Final product was stored as a chloroform stock solution desiccated under argon at y208C. Periodic assays of the stock solution by thin-layer chromatography showed no significant development of by-products or impurities.
Preparation of erythrocytes
Human blood was obtained from healthy volunteers by venipuncture, and collected in tubes containing citrate anticoagulant. Erythrocytes were washed 3 Ž . times by centrifugation 1000 = g for 5 min in 150 mM NaCl, and the plasma and buffy coat were discarded. Isolated erythrocytes were then spun at 5000 = g for 5 min, resuspended in 138 mM NaClr5 mM KClr7.5 mM sodium phosphater1 mM Ž . Ž . MgSO r5 mM glucose pH 7.4 buffer A , and 4 stored at 48C until ready for use. Typically cells were used within 10 h of collection, and all cell incubations were done in capped plastic tubes. Final ery-Ž . throcyte concentrations were 20% hematocrit hct unless otherwise noted.
Vesicle preparation
Stock lipid solutions were dried down under a gentle stream of argon or nitrogen, then resuspended in buffer A. Suspensions were bath-sonicated to clarity, to produce small unilamellar vesicles. In experiments employing PS, magnesium and glucose were omitted from buffer A and sonication was carried out under argon. 
Treatment of erythrocytes with Õanadate and chlorpromazine
Vanadate and CPZ were introduced to erythrocyte suspensions from stock solutions of phosphate-free Ž . isotonic saline 5 mM vanadate and 6 mM CPZ . Vanadate solutions were stored at room temperature, while CPZ solutions were prepared fresh daily. Typically vanadate stock solutions were prepared fresh monthly, although vanadate stock stored over 6 months appeared to inhibit PS translocation as com-Ž . pletely as freshly made stock data not shown .
Cell suspensions in buffer A were preincubated with 100 mM vanadate at 378C for 10-20 min. Samples were then treated with 100-200 mM CPZ at 378C for up to 8 h. At these CPZ concentrations, significant drug-membrane interactions are reported, w x with minimal cell lysis 17, 19, 20, 23, 24 . For incubations lasting 6 h or more, cell suspensions contained Ž antibiotics 80 to 100 U penicillinrml, 80 to 100 mg . streptomycinrml . For 08C incubations, samples were transferred to a 08C ice bath after vanadate preincubation, and allowed to sit at 08C for 30 to 50 min before CPZ addition. In all experiments, control cell sample incubation times and temperatures were identical to incubations of experimental samples.
Treatment of erythrocytes with calcium
Calcium and ionophore were added to erythrocyte suspensions from stock solutions. 
Cell samples containing C DLPC were diluted Ž to 5% hct in buffer A with or without BSA 10% . wrv final concentration , and incubated at 378C for 20 min. This treatment extracts radiolabeled lipids to a steady-state maximum; samples treated with BSA for an additional 25 min showed no additional extrac-Ž . tion data not shown . For vanadate-treated samples, all extraction buffers contained 100 mM vanadate. Following treatment with BSA, samples were pelleted by centrifugation at 13600 = g for 30 s, and supernatants were removed. Pellets were lysed with Ž . Triton X-100 8%, vrv , transferred to scintillation Ž vials, and bleached by addition of sodium azide 20 . Ž . mM followed by hydrogen peroxide 6-9%, vrv . Sample vials were heated at 60-808C overnight, then Ž EcoLite scintillation cocktail ICN Biomedicals, Inc., . Irvine, CA was added to each vial, and disintegra-Ž . tions per minute dpm for each pellet sample was ( )determined on a liquid scintillation counter, model Ž . LS 3801 Beckman Instruments, Palo Alto, CA , using standard quench curves. Percentages of total radiolabel remaining in the pellets were calculated using the formula: % 14 C y PC in pellet dpm from BSA y extracted pellet s 100 = dpm from buffer A y extracted pellet 1 Ž .
Prothrombinase assay for outer monolayer PS ( [ ] ) modified from 13,33,34
Erythrocyte samples in buffer B were incubated at 378C for 410 min, while treated concurrently with vanadate and CPZ, or calcium as described above, for time periods indicated in table legends. Samples then were washed 2-3 times by centrifugation at 1000-3000 = g for 5 min at 48C, in 120 mM NaClr50 mM Ž .Ž . Trisr6 mM CaCl P 2H O pH 7.8 buffer C , ensur- 2 2 ing removal of any membrane fragments. Following Ž dilution to 0.1% hct with a mixture of factor V 5 . Ž y 1 . Ž nM , factor Xa 0.3 U ml , and prothrombin 1.3 U y1 . ml in buffer C, samples were incubated at 378C for 4-6 min to produce thrombin; this reaction was Ž . halted by the addition of 15 mM EDTA pH 7.4 . After centrifugation at 13600= g for 30 s, supernatant aliquots were combined with 100 mM prothrombin substrate. Emergence of chromogenic cleavage product was monitored at 404 nm on a diode array spectrophotometer, model HP 8452A Ž . Hewlett-Packard Co., Palo Alto, CA . Initial zero-Ž . order rates of absorbance increase V were determax Ž mined using HP 89532 software Hewlett-Packard . Co. . Readings were not converted to actual concentrations of exposed PS, but were used to indicate the relative amounts of exposed PS in control and experimental samples.
Determination of hemoglobin
Results of the prothrombinase assay were normalized for hemoglobin concentration in each sample. For hemoglobin determination, cell samples were diluted 1:4 with 0.8 mM KCNr0.6 mM Ž . K Fe CN r1.0 mM KH PO in Triton X-100 3 6 2 4 Ž . 0.05% vrv , allowed to react at room temperature for at least 30 min, and analyzed spectrophotometriw x cally at 540 nm 35 . Supernatants of cell samples were also assayed in this manner to determine percent cell lysis per sample.
Results
All figures and tables report results of typical experiments.
CPZ-induced shape change in Õanadate-treated erythrocytes
Cell suspensions were preincubated in buffer A in the presence or absence of vanadate, which inhibits active aminophospholipid translocation. Samples were Ž . then treated with CPZ and incubated at 08C to-stomatocyte shape transformation that stabilized after approx. 1 h, when cells were predominantly monoinvaginated stomatocytes. This level of stomatocytosis was stable for at least 6 h at 08C. Transformation of shape occurred whether or not cells were pretreated with 100 mM vanadate for 10 min, although typically slightly less stomatocytosis was observed with vanadate pretreatment. CPZ-free control cells remained discocytic over the 7 h incubation; vanadate-pretreated samples became slightly echinocytic.
Ž . At 378C Fig. 1B , samples treated with vanadate or CPZ alone exhibited shape transformations very similar to the same samples at 08C; vanadate-treated cells crenated slightly, and CPZ-treated cells developed rapid stomatocytosis that was slightly greater than at 08C. However, when CPZ was added to vanadate-pretreated cells at 378C, a triphasic shape progression occurred, in contrast to stable stomatocytosis observed at 08C. Cells at 378C first underwent a Ž stomatocytic transformation from MI sy0.15 to . y0.98 within the first minute of CPZ addition. With continued incubation, stomatocytosis was reversed, and by 70 min after CPZ addition, cells were slightly Ž . echinocytic MI s q0.58 . Echinocytosis reached maximum extent by about 2 h, at which point a gradual stomatocytic reversion occurred, reaching MI sy0.46 by 7 h. Similar shape progressions were also induced when vanadate was added up to 3.5 h Ž . after CPZ addition Fig. 2 ; in each case the stomatocytes reverted transiently toward echinocytic morphology, then returned again to cupped forms. Table 2 w C
DLPC back extraction of CPZ-treated erythrocytes
To assess the transbilayer distribution of PC in erythrocytes treated with CPZ at 08C and 378C, samw 14 x ples that had been prelabeled with C DLPC were subjected to extraction by BSA, to remove any radiolabeled lipid from the outer monolayer of the cells w x 18,36 . Radioactivity remaining with the cell pellet was attributed to radiolabeled lipid in the inner monolayer.
After short incubations, similar percentages of radiolabel dpm were retained in the pellets of CPZ-free Ž . Ž . samples at 08C 11.6% Table 1 , and at 378C Ž .Ž . 13.5% Table 2 , reflecting the normal predominant w x outer monolayer disposition of native PC 8 . At 08C Ž . Table 1 , percentage of dpm inaccessible to BSA extraction changed very little over the course of a 6-h incubation in the presence or absence of CPZ. In CPZ-free cell samples, morphologies remained discoid throughout the incubation, while the percentage of pellet-associated dpm remained unchanged. Incubation with CPZ produced stomatocytosis to MI s y0.81 after 345 min, a change that was not accompanied by a significant increase in pellet-associated counts. This suggests that at 08C, very little transbi- Table 2 , PC redistribution was apparent over time. Initially, there was no difference in relative radiolabel extractability between CPZ-free and CPZ-treated samples. In CPZ-free samples, pellet-associated dpm increased from 13.5% of total counts at 18 min to 17.2% at 380 min, while morphologies remained discoid. This suggests a slow redistribution of radiolabel from the outer to inner monolayer at 378C over this time course, indicative of passive w x DLPC flip-flop 37,38 . With CPZ treatment, the fractional increase in pellet-associated dpm was much greater, rising from 13.0% of total counts after 3 min of CPZ treatment to 28.1% after 360 min of treatment. This indicates a drug-induced acceleration of PC transbilayer redistribution. Concurrently, cells became slightly more stomatocytic. However, CPZ-induced stomatocytosis had already developed at the Ž . earliest extraction time MI sy0.84 , while the shape change became only slightly more extensive with the following hours of incubation. Thus, as at 08C, there is no apparent kinetic correlation between CPZ-induced PC scrambling and stomatocytosis.
Vanadate had no significant independent effect on w 14 x Ž . the extractability of C DLPC at 378C Table 3 . After 7.5 h of incubation, cells treated with 100 mM vanadate alone showed a slight increase in unextractable dpm compared to cells without vanadate, consistent with a previous report of vanadate-induced w x redistribution of PC in the bilayer 39 . Vanadate also did not have a significant effect on net radiolabel redistribution induced by CPZ. After 1.5-2.5 h of incubation at 378C in the absence of vanadate, the unextractable PC fraction was 5% greater in the CPZ-treated sample than in the CPZ-free control Ž . control, 11.9%; CPZ sample, 16.8% . A similar small increase was observed in samples pretreated Ž . with vanadate control, 12.6%; CPZ sample, 18.2% . After 6.5-7.5 h of incubation, pellet-associated counts in each of the CPZ-treated samples had risen by 10-13% of the total, relative to the corresponding Ž control i.e., the fractional increase in pellet-associated counts was similar in the presence or absence of . vanadate . These results are consistent with a similar study of vinblastine-invaginated cells, in which vanadate was not observed to affect the transbilayer distriw x bution of spin-labeled sphingomyelin probes 18 .
In all samples, percent cell lysis increased over Ž . time, but never exceeded 4% Tables 1-3 . However, w 14 x since C DLPC extractability tended to decrease over time, this level of lysis did not compromise the qualitative interpretation of these results. Decreased accessibility of radiolabel with time was not due to BSA degradation; extended incubations of control w 14 x samples enriched with 50% more C DLPC showed Table 4 Prothrombinase assay for outer monolayer PS in vanadaterCPZ-treated erythrocytes at 378C proportionately more extraction, indicating no significant decrease in the extraction capacity of BSA in Ž . this time domain data not shown .
Prothrombinase assay for outer monolayer PS in Õanadate-pretreated, CPZ-treated erythrocytes
To assess the transbilayer distribution of endogenous PS in erythrocytes, a prothrombinase assay was used. In this assay, the presence of outer monolayer PS initiates a coagulation cascade, resulting in a dose-dependent liberation of chromophore from prow x thrombin substrate 13,33,40 . This PS assay was chosen over others for two reasons. First, it assays for endogenous PS, eliminating the need for introducing Ž foreign PS probes such as short-chain PS homologs . or spin labels which may not necessarily mimic the behavior of the native species. In addition, the assay should not remove or destroy membrane components, thereby reducing disruptions in membrane activity w x and integrity 33 .
Of the samples tested for outer monolayer PS Ž . Table 4 , cells treated with calcium and ionophore produced the highest rate of absorbance increase at 404 nm, indicating the most thrombin-induced cleavage of chromogenic substrate, and the most outer monolayer PS. This indicates extensive scrambling of membrane PS by calcium treatment, in agreement w x with previous reports 34,39,40 . Vanadate-treated cells without CPZ showed the lowest activity of the samples tested, producing only 15% of the activity seen with calcium-treated cells 2 . With the addition of CPZ to vanadate-pretreated cells at 378C, prothrombinase activity increased with longer CPZ incubation times. Increase was apparent even after 410 min, when activity was 50% higher Ž than in the sample initially exposed to CPZ but still only 35% of the activity in the calcium-treated sam-. ple . This suggests a continual CPZ-induced movement of membrane PS from the inner to outer mono- 2 When normalized for lipid phosphate, sonicated rbc membrane fragments produced a prothrombinase activation rate twofold higher than cells calcium-loaded under the conditions noted. This result is offered for qualitative comparison; however, it is probably not valid to make quantitative comparisons of prothrombinase activation data obtained using membranes of widely vary-Ž . ing configurations M.S. Moxness, personal communication . Fig. 3 . DLPS-induced shape change of vanadate-pretreated erythrocytes at 378C. Cells were preincubated with 100 mM vana-Ž . Ž . Ž . date for 0 min circles , 15 min triangles , or 7.5 h squares . At time zero, 40 mM DLPS was added to each cell sample, and the resulting morphologies were monitored over time.
layer. Cell morphologies during this time course were typical of the triphasic shape progression seen with CPZ-treated cells pretreated with vanadate: stomato-Ž . cytic upon CPZ addition MI sy1.22 , discocytic at Ž . 100 min MI sq0.08 , then gradually reverting to Ž . stomatocytes MI sy1.17 at 410 min . Thus, there is no direct correlation between PS transbilayer distribution and the triphasic shape progression of these Ž . cells Table 4 .
DLPS-induced shape change in Õanadate-pretreated erythrocytes
The role of aminophospholipid translocation in long-term cell shape transformations was examined in vanadate-treated cells. Erythrocytes were preincubated at 378C with vanadate for 7.5 h, the time required for vanadate-pretreated, CPZ-treated cells to Ž . pass through their triphasic shape change Fig. 1B . Ž . Upon DLPS addition Fig. 3 , vanadate-free cells became slightly echinocytic after 3 min, followed by a stomatocytic transformation that stabilized by 20 min after lipid addition. Such a shape progression is indicative of exogenous PS incorporation into the outer monolayer to produce echinocytes, followed by conversion to stomatocytes as PS is transported to the w x inner monolayer 16 .
With a 15-min vanadate preincubation followed by Ž . DLPS treatment Fig. 3 , cells became highly Ž . echinocytic MI sq2.02 after 6 min , and did not ( )revert in shape until after 20 min of lipid incubation, eventually dropping to MI sy0.27 after 90 min of incubation with DLPS. With a 7.5-h vanadate preincubation, cells then treated with DLPS became simi-Ž . larly echinocytic MI sq1.68 after 6 min . However, after only 10 min the shapes of these cells began to revert, returning to the morphology of vana-Ž . date-free cells after 90 min MI sy1.03 . These results indicate that with extended vanadate incubation, aminophospholipid translocase activity was partially restored.
Discussion
The mechanism of CPZ-induced stomatocytosis in erythrocytes has long been under study. Early work w x suggested 19 that stomatocytosis occurred by intercalation of cationic CPZ molecules into the anionic inner monolayer of the erythrocyte membrane, resulting in net inner monolayer expansion and inward Ž . membrane buckling the bilayer couple hypothesis . Indeed, with a ghost membrane:aqueous phase partiw x tion coefficient of 1000 to 5500 23,41,42 , CPZ should readily incorporate into erythrocyte membranes. Recent studies suggest CPZ-induced effects involving cytofacial components such as skeletal prow x w x teins 43 and phosphoinositides 44 , reinforcing the likelihood of an inner monolayer disposition.
Other studies implicate stomatocytic mechanisms more complicated than inner monolayer intercalation, such as inhibition of calmodulin-regulated activities w x w x 45 and CPZ-induced lipid scrambling 18 . However, CPZ-induced stomatocytosis does not appear to be related to either of these events. In the case of calmodulin inhibition, a number of stomatogenic amphipaths were found to inhibit calmodulin very little w x 46 . CPZ-induced shape change was also not correlated with changes in calmodulin-dependent memw x brane protein phosphorylation 47 . Additionally, Ž metabolic processes such as those regulated by . calmodulin and calmodulin-dependent kinases are inhibited significantly at low temperatures. If calmodulin inhibition were solely responsible for stomatocytosis, then cooling normal cells to 08C should produce a stomatocytic response. In fact, normal cells Ž . remain discoid upon cooling to 08C Fig. 1A .
The lipid scrambling mechanism provides an alternative based not on the bilayer distribution of CPZ, but on redistribution of endogenous lipids. Schrier w x and co-workers 18 propose that CPZ and related amphipaths may induce stomatocytosis by a combina-Ž . tion of 1 drug-induced bilayer scrambling of all phospholipids, which could introduce aminophospholipids to the outer monolayer without affecting mor-Ž . phology; and 2 flippase-mediated selective translocation of aminophospholipids back to the inner monolayer. Absent a rapid mechanism for restoring scrambled choline lipids to the outer monolayer, these events result in net expansion of the inner monolayer. Several of the present findings are inconsistent with this hypothesis as the primary mode of CPZ action. First, the model invokes two temperature-sensitive processes, phospholipid flip-flop and aminophospholipid translocation, both of which are inhibited severely at 08C. If the immediate cause of CPZ-induced stomatocytosis is translocation of scrambled PS, then no CPZ effect should be apparent at 08C. In Ž . fact, CPZ induces rapid t -5 min stomatocytosis 1r2 at 08C, under conditions where PS transport is abolw x w 14 x ished 48 . BSA extraction of C DLPC indicates that CPZ-induced lipid scrambling is likewise inhib-Ž . ited at 08C Table 1 . While the magnitude of CPZ Ž . stomatocytosis is greater at 378C than at 08C Fig. 1 , its occurrence at 08C cannot be attributed to phospholipid redistribution.
The CPZ-induced shape effect can also be decoupled from lipid scrambling at 378C, by using a concentration of CPZ that generates only monoinvaginated stomatocytes and by analyzing very early cell Ž . responses Table 2 . Although both CPZ-induced rew 14 x distribution of C DLPC and gradual increase in stomatocytic extent are observed over time, consistent with native PC scrambling, substantial stomatow 14 x cytosis is evident well before C DLPC redistribution can be detected. Thus, lipid scrambling does not appear to play a role in the immediate drug-induced shape change at 378C, but may be important in mediating subsequent morphological events. The earw x lier study 18 employed higher drug concentrations than this work, which may accelerate the phospholipid redistribution. This would complicate interpretation by superimposing several complex but kinetically distinguishable responses.
The lipid redistribution mechanism is also not supported by results of experiments using vanadate-( )pretreated erythrocytes. Earlier reports provide evidence that drug-induced stomatocytosis and endocyw x tosis are inhibited in the presence of vanadate 18,49 . Indeed, immediately upon addition of vanadate to CPZ-treated cells, stomatocytosis begins to reverse Ž . Fig. 2 , consistent with those reports. Such inhibition could reflect outer monolayer expansion by drugscrambled aminophospholipid, trapped in the outer w x monolayer due to flippase inactivation 18 . However, if cells are pretreated with vanadate and then exposed to low concentrations of CPZ, an early immediate stomatocytosis is observed, followed by reversion to Ž . echinocytes over a 1-h interval Fig. 1B . Unless early time-points are monitored, the overall shape effect appears to be simple inhibition of stomatocytosis. Thus, as with vanadate-free cells, the biphasic nature of the shape change seen with vanadate pretreatment suggests a two-event process: intercalation of CPZ to produce immediate stomatocytosis, fol-Ž lowed by general drug-induced lipid scrambling Ta-. ble 3 and net redistribution of PS to the outer monolayer resulting in crenation. Such accumulation of PS in the outer monolayer is indicated by the increased prothrombinase activity of these cells with Ž . time Table 4 .
Prolonged incubations of cells with vanadate and CPZ reveal a third phase in this complex shape response: a gradual reversion to stomatocytes over several hours. The mechanism behind this phase of the shape change is not evident, as several aspects are difficult to reconcile with any simple model. During the time frame of the third shape response, vanadate inhibition of the flippase is apparently partially re-Ž . versed, as indicated by morphology assay Fig. 3 . This might suggest that several hours after vanadate and CPZ addition, flippase activity is partially restored, allowing scrambled outer monolayer PS to be slowly transported back into the inner monolayer, producing stomatocytes 3 . However, in this same extended time domain, activation of prothrombinase Ž . increases slightly Table 4 , which is not consistent with a net inward movement of PS. Hence, the mechanism behind this part of the triphasic shape 3 CPZ is reported to reduce vanadate to vanadyl cation in free w x aqueous solution 50 , and intracellular vanadyl acts as a relaw x tively inefficient flippase inhibitor 51 . change appears to be complex, and requires further study.
While lipid scrambling may offer a partial contribution to overall CPZ-induced stomatocytosis, it appears that selective inner monolayer intercalation of the amphipath still provides the most general explanation for its morphological effects. Ongoing studies will address preferential binding of CPZ with cytofacial membrane components.
